Large Biotech Makes Cost Savings Of $1.8 Million In Phase III Study
Large Biotech Makes Cost Savings Of $1.8 Million In Phase III Study
4 PagesCASE STUDY LARGE BIOTECH MAKES COST SAVINGS OF $1.8 MILLION IN PHASE III STUDY Large biotech makes cost savings of $1.8 million in Phase III study by engaging Almac’s Supply Chain Management expertise to manage the drug supply for a high value biological product.BACKGROUND Our client, a large biotech company, was planning a multinational, phase III trial involving 800 patients to compare the efficacy, safety and tolerability of the Inv
